blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2542228

EP2542228 - PULSATILE DRUG RELEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.10.2018
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  27.10.2017
FormerGrant of patent is intended
Status updated on  20.10.2017
FormerExamination is in progress
Status updated on  18.09.2017
FormerGrant of patent is intended
Status updated on  20.04.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL, IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
University of Strathclyde
McCance Building 16 Richmond Street
Glasgow G1 1XQ / GB
[2017/48]
Former [2013/02]For all designated states
University of Strathclyde
McCance Building 16 Richmond Street
Glasgow G1 1XQ / GB
Inventor(s)01 / MULLEN, Alexander
Strathclyde Institute of Pharmacy and Biomedical
Sciences
University of Strathclyde
161 Cathedral Street
Glasgow Strathclyde G4 0RE / GB
02 / STEVENS, Howard
Strathclyde Institute of Pharmacy and Biomedical
Sciences
University of Strathclyde
161 Cathedral Street
Glasgow Strathclyde G4 0RE / GB
03 / ECCLESTON, Sarah
Flat 5 12 Riverview Place
Glasgow Strathclyde G5 8EH / GB
 [2013/02]
Representative(s)Chapman, Paul Gilmour, et al
Marks & Clerk LLP
40 Torphichen Street
Edinburgh EH3 8JB / GB
[N/P]
Former [2013/42]Chapman, Paul Gilmour, et al
Marks & Clerk LLP
Atholl Exchange
6 Canning Street
Edinburgh EH3 8EG / GB
Former [2013/02]Chapman, Paul Gilmour
Marks & Clerk LLP Aurora 120 Bothwell Street
Glasgow G2 7JS / GB
Application number, filing date11709763.404.03.2011
[2017/48]
WO2011GB00306
Priority number, dateGB2010000376605.03.2010         Original published format: GB 201003766
[2013/02]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011107749
Date:09.09.2011
Language:EN
[2011/36]
Type: A2 Application without search report 
No.:EP2542228
Date:09.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 09.09.2011 takes the place of the publication of the European patent application.
[2013/02]
Type: B1 Patent specification 
No.:EP2542228
Date:29.11.2017
Language:EN
[2017/48]
Search report(s)International search report - published on:EP03.05.2012
ClassificationIPC:A61K9/28, A61K9/22, A61K9/24
[2013/02]
CPC:
A61K9/2866 (EP,US); A61K31/437 (EP); A61K9/282 (EP,US);
A61K9/288 (EP,US); A61P25/20 (EP); A61K9/209 (EP,US);
Y02A50/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/02]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PULSIERENDE WIRKSTOFFFREISETZUNG[2013/02]
English:PULSATILE DRUG RELEASE[2013/02]
French:LIBÉRATION PULSATILE DE MÉDICAMENT[2013/02]
Entry into regional phase31.08.2012National basic fee paid 
31.08.2012Designation fee(s) paid 
31.08.2012Examination fee paid 
Examination procedure31.08.2012Amendment by applicant (claims and/or description)
31.08.2012Examination requested  [2013/02]
14.10.2014Despatch of a communication from the examining division (Time limit: M06)
24.04.2015Reply to a communication from the examining division
21.01.2016Despatch of a communication from the examining division (Time limit: M06)
28.07.2016Reply to a communication from the examining division
21.04.2017Communication of intention to grant the patent
01.09.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
01.09.2017Fee for grant paid
01.09.2017Fee for publishing/printing paid
19.10.2017Information about intention to grant a patent
19.10.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.10.2014
Opposition(s)30.08.2018No opposition filed within time limit [2018/45]
Fees paidRenewal fee
11.03.2013Renewal fee patent year 03
12.03.2014Renewal fee patent year 04
10.03.2015Renewal fee patent year 05
10.03.2016Renewal fee patent year 06
10.03.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL29.11.2017
CY29.11.2017
EE29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
MK29.11.2017
RS29.11.2017
SM29.11.2017
LU04.03.2018
MT04.03.2018
IS29.03.2018
[2020/33]
Former [2020/31]CY29.11.2017
EE29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
MK29.11.2017
RS29.11.2017
SM29.11.2017
LU04.03.2018
MT04.03.2018
Former [2020/08]CY29.11.2017
EE29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
RS29.11.2017
SM29.11.2017
LU04.03.2018
MT04.03.2018
Former [2019/04]CY29.11.2017
EE29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
RS29.11.2017
SM29.11.2017
LU04.03.2018
Former [2018/52]CY29.11.2017
EE29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
RS29.11.2017
SM29.11.2017
Former [2018/37]CY29.11.2017
EE29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
RS29.11.2017
SM29.11.2017
Former [2018/25]HR29.11.2017
LT29.11.2017
LV29.11.2017
RS29.11.2017
Former [2018/22]LT29.11.2017
Cited inInternational search[XY] US2009297601  (VERGNAULT GUY et al.) [Y] 2,4-6,11-15
 [Y] US2009155358  (DIAZ LILIANA ELISABETH et al.) [Y] 2,4-6,11-15 * paragraph [0036] * * paragraph [0040] - paragraph [0041] * * paragraph [0045] * * paragraph [0054] - paragraph [0055] * * paragraph [0061] - paragraph [0063] * * paragraph [0065] *
 [Y] EP1064937  (SANOFI SYNTHELABO et al.) [Y] 4-6,11-15 * paragraph [0013] * * paragraph [0022] - paragraph [0023] *
 [A] US2007098788  (GORE SUBHASH P et al.) [A] 1-15 * paragraph [0001] - paragraph [0002] * * paragraph [0004] - paragraph [0005] * * paragraph [0016] - paragraph [0017] *
 [XY]   GHIMIRE ET AL: "In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: A pharmacoscintigraphic study in the beagle dog", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 67, no. 2, 8 August 2007 (2007-08-08), pages 515 - 523, XP022190569, ISSN: 0939-6411, DOI: 10.1016/J.EJPB.2007.03.002

DOI:   http://dx.doi.org/10.1016/j.ejpb.2007.03.002
by applicant  STEVENS HNE: "Chronopharmaceutical Drug Delivery", J PHARM PHARMAC., vol. 50, no. S, 1998, pages 5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.